X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15881) 15881
Newsletter (118) 118
Book Chapter (30) 30
Magazine Article (28) 28
Newspaper Article (26) 26
Dissertation (10) 10
Publication (9) 9
Conference Proceeding (3) 3
Streaming Video (2) 2
Transcript (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12032) 12032
science & technology (7075) 7075
life sciences & biomedicine (6914) 6914
male (6748) 6748
female (6642) 6642
cytarabine - administration & dosage (6601) 6601
adult (5109) 5109
middle aged (5104) 5104
antineoplastic combined chemotherapy protocols - therapeutic use (4644) 4644
cytarabine - therapeutic use (3915) 3915
cytarabine - pharmacology (3789) 3789
oncology (3497) 3497
aged (3409) 3409
hematology (3352) 3352
animals (3278) 3278
leukemia, myeloid, acute - drug therapy (2990) 2990
adolescent (2946) 2946
cytarabine (2562) 2562
remission induction (2064) 2064
cytarabine - adverse effects (1896) 1896
child (1811) 1811
treatment outcome (1784) 1784
mice (1731) 1731
abridged index medicus (1526) 1526
antineoplastic combined chemotherapy protocols - adverse effects (1502) 1502
chemotherapy (1501) 1501
daunorubicin - administration & dosage (1441) 1441
etoposide - administration & dosage (1344) 1344
prognosis (1338) 1338
acute disease (1331) 1331
antineoplastic combined chemotherapy protocols - administration & dosage (1276) 1276
methotrexate - administration & dosage (1236) 1236
child, preschool (1223) 1223
vincristine - administration & dosage (1219) 1219
cyclophosphamide - administration & dosage (1211) 1211
time factors (1205) 1205
cancer (1149) 1149
leukemia (1101) 1101
combined modality therapy (1092) 1092
dose-response relationship, drug (1019) 1019
leukemia - drug therapy (990) 990
acute myeloid leukemia (983) 983
disease-free survival (944) 944
recurrence (934) 934
drug therapy, combination (922) 922
doxorubicin - administration & dosage (905) 905
leukemia, myeloid - drug therapy (888) 888
drug administration schedule (886) 886
cell line (873) 873
antineoplastic agents - therapeutic use (849) 849
survival rate (810) 810
cells, cultured (787) 787
retrospective studies (773) 773
infant (765) 765
survival analysis (748) 748
leukemia, myeloid, acute - pathology (736) 736
prednisone - administration & dosage (727) 727
aged, 80 and over (692) 692
follow-up studies (688) 688
daunorubicin - therapeutic use (686) 686
antineoplastic agents - pharmacology (680) 680
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (672) 672
cytarabine - metabolism (668) 668
leukemia, myeloid, acute - mortality (664) 664
vincristine - therapeutic use (658) 658
transplantation (653) 653
cyclophosphamide - therapeutic use (644) 644
young adult (639) 639
cytarabine - analogs & derivatives (638) 638
kinetics (626) 626
pharmacology & pharmacy (626) 626
mitoxantrone - administration & dosage (618) 618
bone marrow transplantation (600) 600
idarubicin - administration & dosage (591) 591
rats (587) 587
methotrexate - therapeutic use (571) 571
hematopoietic stem cell transplantation (562) 562
drug resistance (553) 553
cell division - drug effects (551) 551
research (545) 545
antineoplastic agents - administration & dosage (543) 543
cell survival - drug effects (541) 541
drug synergism (540) 540
care and treatment (512) 512
transplantation, autologous (505) 505
leukemia, myeloid, acute - genetics (503) 503
leukemia, lymphoid - drug therapy (498) 498
antimetabolites, antineoplastic - administration & dosage (497) 497
lymphoma, non-hodgkin - drug therapy (494) 494
tumor cells, cultured (492) 492
cytarabine - toxicity (491) 491
antimetabolites, antineoplastic - therapeutic use (481) 481
dexamethasone - administration & dosage (481) 481
stem cells (476) 476
thioguanine - administration & dosage (470) 470
medicine & public health (469) 469
apoptosis (455) 455
apoptosis - drug effects (449) 449
cytosine arabinoside (449) 449
bone marrow - pathology (443) 443
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (14609) 14609
Japanese (695) 695
German (281) 281
Chinese (247) 247
French (200) 200
Russian (143) 143
Spanish (135) 135
Polish (103) 103
Italian (88) 88
Czech (23) 23
Portuguese (21) 21
Hungarian (14) 14
Danish (12) 12
Dutch (10) 10
Korean (8) 8
Norwegian (6) 6
Hebrew (5) 5
Turkish (5) 5
Arabic (4) 4
Romanian (4) 4
Serbian (4) 4
Slovak (4) 4
Croatian (3) 3
Swedish (3) 3
Bosnian (1) 1
Bulgarian (1) 1
Indonesian (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 1097-0142, 03/2007, Volume 109, Issue 6, pp. 1114 - 1124
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 07/2012, Volume 30, Issue 21, pp. 2670 - 2677
Journal Article
Cancer, ISSN 0008-543X, 08/2017, Volume 123, Issue 16, pp. 3050 - 3060
Journal Article
The New England journal of medicine, ISSN 1533-4406, 03/2011, Volume 364, Issue 11, pp. 1027 - 1036
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2009, Volume 374, Issue 9700, pp. 1512 - 1520
Summary Background Chemotherapy with high-dose methotrexate is the conventional approach to treat primary CNS lymphomas, but superiority of polychemotherapy... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Lymphoma, Non-Hodgkin - radiotherapy | Cranial Irradiation - methods | Central Nervous System Neoplasms - radiotherapy | Adult | Lymphoma, Non-Hodgkin - drug therapy | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Logistic Models | Treatment Outcome | Combined Modality Therapy | Remission Induction | Methotrexate - adverse effects | Antimetabolites, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Aged | Lymphoma, Non-Hodgkin - mortality | Central Nervous System Neoplasms - drug therapy | Central Nervous System Neoplasms - mortality | Cytarabine | Patient outcomes | Central nervous system diseases | Dosage and administration | Lymphomas | Drug therapy, Combination | Methotrexate | Drug therapy | Data analysis | Disease | Monoclonal antibodies | Data collection | Radiation therapy | Patients | Tropical diseases | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 08/2017, Volume 377, Issue 5, pp. 454 - 464
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 03/2017, Volume 376, Issue 10, pp. 917 - 927
Journal Article